DRUG-seq for miniaturized high-throughput transcriptome profiling in drug discovery
Open Access
- 17 October 2018
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature Communications
- Vol. 9 (1), 1-9
- https://doi.org/10.1038/s41467-018-06500-x
Abstract
Here we report Digital RNA with pertUrbation of Genes (DRUG-seq), a high-throughput platform for drug discovery. Pharmaceutical discovery relies on high-throughput screening, yet current platforms have limited readouts. RNA-seq is a powerful tool to investigate drug effects using transcriptome changes as a proxy, yet standard library construction is costly. DRUG-seq captures transcriptional changes detected in standard RNA-seq at 1/100th the cost. In proof-of-concept experiments profiling 433 compounds across 8 doses, transcription profiles generated from DRUG-seq successfully grouped compounds into functional clusters by mechanism of actions (MoAs) based on their intended targets. Perturbation differences reflected in transcriptome changes were detected for compounds engaging the same target, demonstrating the value of using DRUG-seq for understanding on and off-target activities. We demonstrate DRUG-seq captures common mechanisms, as well as differences between compound treatment and CRISPR on the same target. DRUG-seq provides a powerful tool for comprehensive transcriptome readout in a high-throughput screening environment.This publication has 34 references indexed in Scilit:
- STAR: ultrafast universal RNA-seq alignerBioinformatics, 2012
- RASL‐seq for Massively Parallel and Quantitative Analysis of Gene ExpressionCurrent Protocols in Molecular Biology, 2012
- Digital RNA sequencing minimizes sequence-dependent bias and amplification noise with optimized single-molecule barcodesProceedings of the National Academy of Sciences of the United States of America, 2012
- Loss of DLK expression in WI-38 human diploid fibroblasts induces a senescent-like proliferation arrestBiochemical and Biophysical Research Communications, 2011
- RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genomeBMC Bioinformatics, 2011
- MTML-msBayes: Approximate Bayesian comparative phylogeographic inference from multiple taxa and multiple loci with rate heterogeneityBMC Bioinformatics, 2011
- An overview of Cdk1-controlled targets and processesCell Division, 2010
- Transforming Growth Factor β Engages TACE and ErbB3 To Activate Phosphatidylinositol-3 Kinase/Akt in ErbB2-Overexpressing Breast Cancer and Desensitizes Cells to TrastuzumabMolecular and Cellular Biology, 2008
- Reconstitution of the Transcription Factor TFIIH: Assignment of Functions for the Three Enzymatic Subunits, XPB, XPD, and cdk7Molecular Cell, 1999
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986